No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
Qiagen Receives FDA Clearance for Gastrointestinal Panel Tests
Insiders At Qiagen Sold US$7.0m In Stock, Alluding To Potential Weakness
Morgan Stanley Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $48
Express News | Qiagen NV : Morgan Stanley Cuts to Equal-Weight From Overweight; Cuts Target Price to $48 From $50
Why Is Qiagen N.V. (QGEN) Among the Top CRISPR Stocks to Invest In?